Coronavirus Disease 2019 (COVID-19) in Solid Organ Transplant Recipients: A Case-Control Study

12 November 2021 : Original article

Alejandro Muñoz Serrano^1ABDEF*, Ana Arias^2ABDE, Víctor Moreno-Torres

^1BE, Jorge Calderón^1B, Natalia Vicente^3DE, Valentín Cuervas-Mons^14ADEF

DOI: 10.12659/AOT.933152

Ann Transplant 2021; 26:e933152

Table 3 Primary and secondary outcomes.

	All patients (N=116)	SOT-recipients (N=32)	No-SOT patients (N=84)	p
Mortality (%)	11 (9.5)	7 (21.9)	4 (4.8)
Severe ARDS (%)	37 (31.9)	9 (28.1)	28 (33.3)	0.59
Days of hospitalization	10.5 [6–17]	8.5 [5.5–21]	11.5 [6.5–16.5]	0.34
Results are expressed as mean±standard deviation and number (percentage). ARDS – acute respiratory distress syndrome.